Back to Search Start Over

Vasodilation and Antihypertensive Activities of Swietenia macrophylla (Mahogany) Seed Extract.

Authors :
Ch'ng YS
Loh YC
Tan CS
Ahmad M
Asmawi MZ
Wan Omar WM
Yam MF
Source :
Journal of medicinal food [J Med Food] 2018 Mar; Vol. 21 (3), pp. 289-301. Date of Electronic Publication: 2018 Feb 08.
Publication Year :
2018

Abstract

The seeds of Swietenia macrophylla King (SM) (Meliaceae) are used as a folk medicine for the treatment of hypertension in Malaysia. However, the antihypertensive and vasorelaxant effects of SM seeds are still not widely studied. Thus, this study was designed to investigate the in vivo antihypertensive effects and in vitro mechanism of vasorelaxation of a 50% ethanolic SM seed extract (SM50) and the fingerprint of SM50 was developed through tri-step Fourier transform infrared (FTIR) spectroscopy. The vasorelaxant activity and the underlying mechanisms of SM50 were evaluated on thoracic aortic rings isolated from Sprague-Dawley rats in the presence of antagonists. The pharmacological effect of SM50 was investigated by oral administration of spontaneously hypertensive rats (SHRs) with three different doses of SM50 (1000, 500, and 250 mg/kg/day) for 4 weeks and their systolic blood pressure (SBP) and diastolic blood pressure (DBP) values were measured weekly using tail-cuff method. The tri-step FTIR macro-fingerprint of SM50 showed that SM50 contains stachyose, flavonoids, limonoids, and ester, which may contribute to its vasorelaxant effect. The results showed that the vasorelaxant activity of SM50 was mostly attributed to channel-linked receptors pathways through the blockage of voltage-operated calcium channels (VOCC). SM50 also acts as both potassium channels opener and inositol triphosphate receptor (IP <subscript>3</subscript> R) inhibitor, followed by β <subscript>2</subscript> -adrenergic pathway, and ultimately mediated through the nitric oxide/soluble guanylyl cyclase/cyclic 3',5'-guanosine monophosphate (NO/sGC/cGMP) signaling pathways. The treatment of SM50 also significantly decreased the SBP and DBP in SHRs. In conclusion, the antihypertensive mechanism of SM50 was mediated by VOCC, K <superscript>+</superscript> channels, IP <subscript>3</subscript> R, G-protein-coupled β <subscript>2</subscript> -adrenergic receptor, and followed by NO/sGC/cGMP signaling mechanism pathways in descending order. The data suggested that SM50 has the potential to be used as a herbal medicament to treat hypertension.

Details

Language :
English
ISSN :
1557-7600
Volume :
21
Issue :
3
Database :
MEDLINE
Journal :
Journal of medicinal food
Publication Type :
Academic Journal
Accession number :
29420109
Full Text :
https://doi.org/10.1089/jmf.2017.4008